Is this our next Big Announcement, page-29

As announced on 24 September 2015, the SPP is being conducted in conjunction with a $6.25m placement.
The proceeds from the placement and SPP will be predominantly used to:
 accelerate development of OBJ’s various pipeline of platform technologies. OBJ has a number of
new platforms in the recently announced DCE technologies and the first personalisation App for
smartphones along with the commercialisation of the Bodyguard program.

SHAREHOLDER UPDATE
28 April 2016
It is expected that feedback from our targeted partnering companies
over the next quarter will more clearly define the three or four market
sectors most suited for the Bodyguard technologies. Discussions and
presentations have now taken place with P&G (who has been
evaluating the UQ data), Reckitt Benckiser and Pfizer, with further
communications planned with GSK, Beiersdorf and other potential
partners who have expressed strong interest in the Bodyguard
technology platform.
Overall, the program is reaching maturity with its first product
(KneeGuard) and the Board remains impressed with the excellent
results being achieved by the OBJ/Bodyguard development team. US
based consultant and FMCG industry expert Dr Steve Meller has been
retained to assist OBJ with partnering discussions and negotiations


October 2016.......... zzzzzzzzzzzzzzzzzzzzz